Usana Health Sciences(USNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

USNA Usana Health Sciences

Not Yet Opened 07-13 16:00:00 EDT

22.03

+0.05

+0.23%

盘后22.03

+0.000.00%

18:47 EDT

High22.43	Low21.89	Vol71.46K
Open21.91	D1 Closing21.98	Amplitude2.46%
Mkt Cap406.61M	Tradable Cap217.33M	Total Shares18.46M
T/O1.58M	T/O Rate0.72%	Tradable Shares9.87M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"USNA","market":"US","secType":"STK","nameCN":"Usana Health Sciences","latestPrice":22.03,"timestamp":1783972800000,"preClose":21.98,"halted":0,"volume":71461,"hourTrading":{"tag":"盘后","latestPrice":22.03,"preClose":22.03,"latestTime":"18:47 EDT","volume":499,"amount":11008.53,"timestamp":1783982844739,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.002274795268425874,"floatShares":9865000,"shares":18456935,"eps":0.482956,"marketStatus":"Not Yet Opened","change":0.05,"latestTime":"07-13 16:00:00 EDT","open":21.91,"high":22.43,"low":21.89,"amount":1583327.79033,"amplitude":0.024568,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.482956,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784016000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":21.98,"postHourTrading":{"tag":"盘后","latestPrice":22.03,"preClose":22.03,"latestTime":"18:47 EDT","volume":499,"amount":11008.53,"timestamp":1783982844739,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.773085,"impliedVol":0.5931,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/USNA","defaultTab":"news","newsList":[{"id":"2644008700","title":"USANA Chief Commercial Officer Brent Neidig sells 5,002 shares worth $97,310.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2644008700","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644008700?lang=en_us&edition=fundamental","pubTime":"2026-06-19 00:14","pubTimestamp":1781799289,"startTime":"0","endTime":"0","summary":"USANA Health Sciences Chief Commercial Officer Brent Neidig sold 5,002 common shares on June 16, 2026.Sale priced at a weighted average $19.45 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL2KLxqQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Chief Commercial Officer Brent Neidig sells 5,002 shares worth $97,310.91","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USNA","BK4183","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767847","title":"USANA Chief Commercial Officer Brent Neidig sells common shares worth $50,542.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767847","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767847?lang=en_us&edition=fundamental","pubTime":"2026-06-17 03:42","pubTimestamp":1781638966,"startTime":"0","endTime":"0","summary":"USANA Health Sciences Chief Commercial Officer Brent Neidig sold 2,511 shares of common stock in mid-June.Sales were executed on June 12 at $20.15 and June 15 at $20.01.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3pKvfj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Chief Commercial Officer Brent Neidig sells common shares worth $50,542.55","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4183","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642405432","title":"USANA Chief People Officer Paul A. Jones sells 5,561 shares for $102,878.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2642405432","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642405432?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:11","pubTimestamp":1780956684,"startTime":"0","endTime":"0","summary":"USANA Health Sciences’ Chief People Officer Paul A. Jones sold 5,561 shares of common stock on June 8, 2026.The shares were sold at USD 18.5 each.Jones reported 0 shares of common stock owned following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL5lPswy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Chief People Officer Paul A. Jones sells 5,561 shares for $102,878.5","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USNA","BK4532","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485090","title":"BRIEF-Usana's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485090","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485090?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:46","pubTimestamp":1780915607,"startTime":"0","endTime":"0","summary":"BRIEF-Usana's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare ProductsJune 8 (Reuters) - USANA Health Sciences Inc USNA.N:USANA'S CELAVIVE CONTOURING FACE & NECK CRME NAMED AMO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUAVHWBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4532","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641850604","title":"USANA's Celavive Contouring Face & Neck CrÈMe Named Among Canada's Top Skincare Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2641850604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641850604?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:46","pubTimestamp":1780915560,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUAVHWBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4183","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640320962","title":"USANA Health Sciences director John Turman Fleming disposes of 2,450 common shares for $43,928.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2640320962","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640320962?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:37","pubTimestamp":1780346274,"startTime":"0","endTime":"0","summary":"USANA Health Sciences director Fleming John Turman Fleming sold 2,450 common shares on June 1, 2026 at USD 17.93.His direct holdings fell to 4,230 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL3DdyQf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Health Sciences director John Turman Fleming disposes of 2,450 common shares for $43,928.5","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4183","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639711236","title":"USANA Chief People Officer Paul A. Jones sells 6,813 shares at $18.95, worth $129,119.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2639711236","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639711236?lang=en_us&edition=fundamental","pubTime":"2026-05-30 01:40","pubTimestamp":1780076400,"startTime":"0","endTime":"0","summary":"USANA Health Sciences Chief People Officer Paul A. Jones sold 6,813 shares of common stock on May 28, 2026.Shares were sold at USD 18.95, cutting his direct stake to 5,561 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLcbBGKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Chief People Officer Paul A. Jones sells 6,813 shares at $18.95, worth $129,119.35","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4532","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697655","title":"USANA CFO Doug Iiekkking sells 5,360 shares for $100,464.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697655","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697655?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:18","pubTimestamp":1779985135,"startTime":"0","endTime":"0","summary":"USANA Health Sciences CFO Doug G. Iiekkking sold 5,360 common shares on May 27, 2026 at $18.75.Transaction left him with 0 shares directly owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL1SRkGg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA CFO Doug Iiekkking sells 5,360 shares for $100,464.40","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USNA","BK4532","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638546533","title":"USANA Health Sciences director Gilbert A. Fuller disposes of 1,057 shares worth $19,735.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2638546533","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638546533?lang=en_us&edition=fundamental","pubTime":"2026-05-26 23:39","pubTimestamp":1779809999,"startTime":"0","endTime":"0","summary":"USANA Health Sciences: Director Gilbert A. Fuller sold 1,057 common shares on May 22, 2026 at a weighted average price of $18.66.The sale left Fuller with 0 shares beneficially owned, held directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL4PW2gM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Health Sciences director Gilbert A. Fuller disposes of 1,057 shares worth $19,735.69","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4183","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637738478","title":"USANA Health Sciences holds annual shareholder meeting, elects eight directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2637738478","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637738478?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:24","pubTimestamp":1779308678,"startTime":"0","endTime":"0","summary":"USANA Health Sciences held its annual shareholder meeting on May 20, 2026.Shareholders backed the slate of eight director nominees for the coming year.KPMG LLP was ratified as the independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLbMVZJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4532","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635228523","title":"USANA Q1 FY26 net earnings attributable to USANA drops 20.1% to $7.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635228523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635228523?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:36","pubTimestamp":1778618197,"startTime":"0","endTime":"0","summary":"USANA Health Sciences net earnings attributable to shareholders fell 20.1% to USD 7.5 million in first quarter ended April 4, 2026, with diluted EPS down to USD 0.41.Net sales edged up 0.3% to USD 250.2 million, as Rise climbed to USD 13.7 million from Protein Pop rollout, offset by Core Nutritional decline to USD 204.4 million and Hiya drop to USD 32.2 million.Gross margin narrowed 2.8 percentage points to 76.2%, reflecting a lower-margin sales mix shift toward Rise and weaker Core Nutritional margins.Core Nutritional active customers fell 12% to 404,000, while Hiya active monthly subscribers slipped to 186,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL5N0Mq7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","USNA","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634668934","title":"USANA Chief Legal Officer Joshua Foukas disposes 3,791 shares worth $75,136.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2634668934","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634668934?lang=en_us&edition=fundamental","pubTime":"2026-05-09 01:25","pubTimestamp":1778261117,"startTime":"0","endTime":"0","summary":"USANA Health Sciences Chief Legal Officer Joshua Foukas sold 3,791 shares of common stock on May 7, 2026 at USD 19.82.Direct holdings fell to 0 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL9mnXtS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"USANA Chief Legal Officer Joshua Foukas disposes 3,791 shares worth $75,136.62","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","USNA","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146963","title":"USANA's People-First Culture Earns Spot on USA Today Top Workplaces List","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146963?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:22","pubTimestamp":1778152920,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA8LS6WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","USNA","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633161282","title":"USANA Hosts Inspiring Spa & Wellness Retreat to Empower Women Across Asia Pacific","url":"https://stock-news.laohu8.com/highlight/detail?id=2633161282","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633161282?lang=en_us&edition=fundamental","pubTime":"2026-05-07 08:30","pubTimestamp":1778113800,"startTime":"0","endTime":"0","summary":"Event centred around USANA's Celavive skincare brand and celebrating the accomplishments of USANA's female Brand PartnersPHUKET, Thailand, May 6, 2026 /PRNewswire/ -- USANA successfully concluded its highly anticipated Celavive skincare spa and wellness retreat held at Club Med Phuket from April 22–24, 2026. This event brought together 79 top qualifying USANA Brand Partners from nine markets across the Asia-Pacific region, including Australia, Hong Kong, Indonesia, Korea, Malaysia, the Philippines, Singapore, Taiwan, and Thailand.Attendees giving back to the Phuket community through the USANA Foundation. The retreat served as a powerful celebration of women, confidence, wellness, and personal growth—offering an experience that extended far beyond skincare. Designed as an immersive wellness journey, the event created a meaningful space for women to reconnect with themselves, and celebrate personal well-being and self-expression.The 79 qualifiers represented the vibrant and growing Celav","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2974281/USANA_Host.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2974281/USANA_Host.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/usana-hosts-inspiring-spa--wellness-retreat-to-empower-women-across-asia-pacific-302764827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EMPW.U","USNA","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633922813","title":"USANA publishes Q1 2026 MD&A report","url":"https://stock-news.laohu8.com/highlight/detail?id=2633922813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633922813?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:55","pubTimestamp":1778014528,"startTime":"0","endTime":"0","summary":"USANA Health Sciences published its Q1 2026 MD&A, highlighting a shift toward an omnichannel model spanning Core Nutritional, Hiya, and Rise Wellness.Reiterated FY 2026 outlook for consolidated net sales of USD 925 million to USD 1 billion; net earnings of USD 20 million to USD 27 million; adjusted diluted EPS of USD 1.95 to USD 2.29.Maintained Hiya FY 2026 net sales forecast of USD 140 million to USD 155 million; expects a stronger second half as subscriber acquisition recovers from earlier Meta-related disruption, supported by launches in Canada and UK, Target distribution, and planned in-house manufacturing savings in 2H 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content us","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL6V4lkZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4581","LU0417517546.SGD","LU1496350502.SGD","COTG","COSW","LU2168564149.EUR","BK4596","LU1069344957.HKD","LU1496350171.SGD","LU2095319765.USD","LU0079474960.USD","IE0008368304.USD","LU1066051225.USD","LU0234572021.USD","LU0238689110.USD","LU1066051498.USD","LU0234570918.USD","LU1571399168.USD","LU1551013342.USD","LU2168564222.USD","LU2210149790.SGD","LU1066053197.SGD","LU0820561909.HKD","LU0823434583.USD","LU2360032135.SGD","LU0943347566.SGD","LU2168563687.JPY","BK4550","BK4155","LU2168564065.EUR","LU2210150020.SGD","USNA","BK4588","BK4585","IE00B5TLWC47.USD","LU0385154629.USD","LU0471298777.SGD","LU1066051811.HKD","IE00BKVL7J92.USD","LU2237438978.USD","BK4504","IE00BZ1G4Q59.USD","LU0471298694.HKD","LU0823434740.USD","LU1116320737.USD","LU1323610961.USD","LU2168564495.EUR","BK4533","LU2381873111.SGD","LU2097829019.USD","BK4532","LU0265550359.USD","LU2360106947.USD","LU1551013425.SGD","LU0689472784.USD","LU0820561818.USD","LU1116320901.HKD","LU2125154778.USD","LU2125154935.USD","LU0256863811.USD","LU1035775433.USD","LU0265550946.USD","HK0000819398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633292127","title":"USANA Health Sciences Q1 revenue flat, profit drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2633292127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633292127?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:33","pubTimestamp":1778013204,"startTime":"0","endTime":"0","summary":"USANA Health Sciences Q1 revenue flat, profit dropsOverviewNutritional supplements maker's fiscal Q1 revenue was flat yr/yr at $250 mlnAdjusted EPS for fiscal Q1 fell 16% yr/yr to $0.61Company reaffir","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL1N41I1E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU2168564065.EUR","LU2168564495.EUR","LU0820561909.HKD","LU0385154629.USD","LU1571399168.USD","LU2360106947.USD","LU0823434583.USD","LU2125154778.USD","LU1116320737.USD","BK4581","LU2168564222.USD","LU0234570918.USD","LU1551013342.USD","COSW","IE00BZ1G4Q59.USD","LU2360032135.SGD","LU1069344957.HKD","LU2381873111.SGD","HK0000819398.USD","USNA","BK4550","LU2210149790.SGD","LU0238689110.USD","LU0823434740.USD","LU1066051811.HKD","IE00B5TLWC47.USD","LU0471298694.HKD","LU0256863811.USD","LU2168564149.EUR","LU2097829019.USD","LU2125154935.USD","LU2210150020.SGD","LU1035775433.USD","LU2237438978.USD","LU1066051225.USD","LU1551013425.SGD","LU0265550359.USD","BK4532","LU1116320901.HKD","BK4183","LU2168563687.JPY","COTG","LU1323610961.USD","BK4155","LU0079474960.USD","LU1496350171.SGD","LU0471298777.SGD","LU0265550946.USD","LU1066053197.SGD","LU0943347566.SGD","LU2095319765.USD","LU0417517546.SGD","BK4504","LU1066051498.USD","LU0234572021.USD","BK4588","IE0008368304.USD","BK4585","BK4533","LU0689472784.USD","LU0820561818.USD","LU1496350502.SGD","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633792953","title":"BRIEF-USANA Health Sciences Q1 EPS USD 0.41","url":"https://stock-news.laohu8.com/highlight/detail?id=2633792953","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633792953?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:15","pubTimestamp":1778012147,"startTime":"0","endTime":"0","summary":"BRIEF-USANA Health Sciences Q1 EPS USD 0.41\n\n\nMay 05 (Reuters) - USANA Health Sciences Q1 sales USD 250 million.\n\nQ1 net earnings USD 7.5 million\noutlook FY EPS USD 1.11-1.45","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXD93531:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4532","USNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633792284","title":"USANA Health Sciences Q1 Adjusted EPS USD 0.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2633792284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633792284?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:15","pubTimestamp":1778012108,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXD93531:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["USNA","BK4183","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633292209","title":"USANA Health Sciences Outlook FY Sales USD 925-1,000 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633292209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633292209?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:15","pubTimestamp":1778012108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXD93531:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["USNA","BK4532","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633087926","title":"USANA Health Sciences Q1 Net Earnings USD 7.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633087926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633087926?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:15","pubTimestamp":1778012108,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXD93531:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4183","USNA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.usana.com","stockEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.1065},{"period":"3month","weight":0.1902},{"period":"6month","weight":0.0757},{"period":"1year","weight":-0.3322},{"period":"ytd","weight":0.1223}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.0852},{"period":"1year","weight":0.2013},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.015206},{"month":2,"riseRate":0.5625,"avgChangeRate":0.01857},{"month":3,"riseRate":0.5625,"avgChangeRate":-0.011266},{"month":4,"riseRate":0.5625,"avgChangeRate":0.059418},{"month":5,"riseRate":0.5625,"avgChangeRate":0.026217},{"month":6,"riseRate":0.625,"avgChangeRate":0.021093},{"month":7,"riseRate":0.4375,"avgChangeRate":-0.001648},{"month":8,"riseRate":0.4,"avgChangeRate":0.007951},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03148},{"month":10,"riseRate":0.4,"avgChangeRate":0.009139},{"month":11,"riseRate":0.533333,"avgChangeRate":-0.036791},{"month":12,"riseRate":0.466667,"avgChangeRate":-0.015698}],"exchange":"NYSE","name":"Usana Health Sciences","nameEN":"Usana Health Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Usana Health Sciences(USNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Usana Health Sciences(USNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Usana Health Sciences,USNA,Usana Health Sciences股票,Usana Health Sciences股票老虎,Usana Health Sciences股票老虎国际,Usana Health Sciences行情,Usana Health Sciences股票行情,Usana Health Sciences股价,Usana Health Sciences股市,Usana Health Sciences股票价格,Usana Health Sciences股票交易,Usana Health Sciences股票购买,Usana Health Sciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Usana Health Sciences(USNA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Usana Health Sciences(USNA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction